Treprostinil Diolamine
Orenitram is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to delay disease progression and to improve exercise capacity.
Systematic Name
Acetic acid, 2-[[(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl]oxy]-, 2,2'-iminobis[ethanol] (1:1).
Anti-hypertensive
Pulmonary Arterial Hypertension
Suitable Formulations
Solid
Approvals
US DMF
EU-WC
